The purpose of this report is to introduce seven new cases and to compare their clinicopathologic features and KRAS mutations to gastric-type intraductal papillary mucinous neoplasms (IPMNs) and intraductal tubulopapillary neoplasms (ITPNs). The gene discussed is KRAS; the disease is pancreatic intraductal papillary-mucinous neoplasm.